211122-38-2 Usage
Uses
Used in Pharmaceutical Industry:
METHYL 6-FLUORO-5-METHYLPYRIDINE-3-CARBOXYLATE is used as a building block for the development of new pharmaceutical products and biologically active substances. Its unique structure allows it to be a key component in the synthesis of various drugs, contributing to the advancement of medicinal chemistry and drug discovery.
Used in Agrochemical Industry:
METHYL 6-FLUORO-5-METHYLPYRIDINE-3-CARBOXYLATE is also used in the synthesis of agrochemicals, playing a role in the development of new pesticides, herbicides, and other agricultural chemicals. Its unique properties make it a valuable component in creating effective and targeted agrochemical products.
Used in Organic Synthesis and Chemical Research:
METHYL 6-FLUORO-5-METHYLPYRIDINE-3-CARBOXYLATE serves as a reagent in organic synthesis and chemical research. Its versatile structure allows it to be used in various chemical reactions, aiding researchers in the development of new compounds and the study of chemical properties and mechanisms.
Check Digit Verification of cas no
The CAS Registry Mumber 211122-38-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,1,1,1,2 and 2 respectively; the second part has 2 digits, 3 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 211122-38:
(8*2)+(7*1)+(6*1)+(5*1)+(4*2)+(3*2)+(2*3)+(1*8)=62
62 % 10 = 2
So 211122-38-2 is a valid CAS Registry Number.
211122-38-2Relevant academic research and scientific papers
OXADIAZOLE MODULATORS OF S1P METHODS OF MAKING AND USING
-
Paragraph 0172, (2017/01/23)
The invention is directed to Compounds of Formula (I): wherein each variable is defined herein, as well as methods of making and using the compounds as agonists of S1P1 and/or S1P5 for instance for treating graft versus host disease and autoimmune diseases.
THIADIAZOLE MODULATORS OF S1P AND METHODS OF MAKING AND USING
-
Paragraph 0154, (2017/01/26)
The invention is directed to compounds of the formula: wherein each of the variables are defined herein, as well as methods of making and using the compounds as agonists of S1P1 and/or S1P5 for instance treating an autoimmune disease.
Modulators of S1P and Methods of Making And Using
-
Page/Page column 64-65, (2010/10/19)
The invention is directed to Compounds of Formula I: as well as methods of making and using the compounds.
